1.Antibiotic Resistance Pattern of Neisseria gonorrhoeae in Hospital Kuala Lumpur, Malaysia (2001-2005)
Azura Mohd Affandi ; HB Gangaram ; Suraiya H Hussein
Malaysian Journal of Dermatology 2007;19(-):35-40
Background Gonorrhoea is the third most common sexually
transmitted infection (after syphilis and non-gonococcal urethritis) seen in patients attending the Genitourinary Medicine (GUM) Clinic in Hospital Kuala Lumpur (HKL). Its association with poor reproductive health outcomes and the increasing prevalence of antimicrobial resistance has made it a major public health concern.
Objective To determine the antibiotic resistance pattern of Neisseria Gonorrhoeae in patients attending the GUM Clinic in HKL and its comparison with other countries.
Method A retrospective study of all patients with gonorrhoea (new and recurrent) between 2001-2005. Antimicrobial susceptibility testing by
standard disc diffusion method was performed to detect sensitivity to penicillin, tetracycline, kanamycin, ciprofloxacin, spectinomycin, ceftriaxone and cefuroxime.
Results A total of 416 positive culture isolates of N.gonorrhoeae from 2001-2005 were reviewed. Highest level of resistance was detected to tetracycline (86.8% of 296 isolates). Resistance to penicillin was noted
in 64.4% of all isolates. Penicillinase Producing N.gonorrhoeae (PPNG) accounted for 62% of cases. Both penicillin and tetracycline showed an
increasing resistance trend from 2001-2005. The third commonest antibiotic resistance was to kanamycin (38.3%), followed by ciprofloxacin (10.4%). The resistance to spectinomycin was 1.7%. No resistance was detected to ceftriaxone and cefuroxime. All gonorrhea
patients in GUM Clinic, HKL were treated with ceftriaxone, and subsequent cultures on follow-up were negative. We compared our results with the data obtained from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP)6 and the WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme (GASP)7.
Conclusion Penicillin and tetracycline resistance remain high in Malaysia and other Western Pacific countries. Resistance to ciprofloxacin was however lower in Malaysia compared to other countries. There was no resistance to ceftriaxone and cefuroxime. The current first line antibiotic for treating gonorrhoea in GUM Clinic, HKL is ceftriaxone.
3.Causes of mortality in patients with psoriasis in Malaysia –Evidence from the Malaysian Psoriasis Registry
Zhenli Kwan ; Chin Aun Yeoh ; Azura Mohd Affandi ; Fatimah Afifah Alias ; Muneer Hamid ; Nurakmal Baharum ; Adrian Sze Wai Yong ; Roshidah Baba
The Medical Journal of Malaysia 2015;70(5):273-277
Background: Patients with severe psoriasis, namely those
requiring phototherapy or systemic treatment, have an
increased risk of death. The aim of this study was to
determine the prevalence, aetiology and risk factors for
mortality among adult patients aged 18 years and above with
psoriasis in Malaysia.
Methods: This was a retrospective study involving adult
patients notified by dermatologists to the Malaysian
Psoriasis Registry between July 2007 and December 2013.
Data were cross-checked against the National Death
Registry. Patients certified dead were identified and the
cause of death was analysed. Multivariate analysis using
multiple logistic regression were conducted on potential
factors associated with higher risk of mortality.
Results: A total of 419 deaths were identified among the
9775 patients notified. There were four significant risk
factors for higher mortality: age>40 years (age 41-60 years
old, Odds Ratio (OR) 2.70, 95%CI 1.75, 4.18; age>60 years
OR 7.46, 95%CI 4.62, 12.02), male gender (OR 1.72, 95%CI
1.33,2.22), severe psoriasis with body surface area (BSA)
>10% (OR 1.52, 95%CI 1.19, 1.96) and presence of at least
one cardiovascular co-morbidity (OR 1.67, 95% CI 1.30,
2.14). Among the 301 patients with verifiable causes of
death, the leading causes were infection (33.9%),
cardiovascular disease (33.6%) and malignancy (15.9%).
Conclusion: Infection was the leading cause of death among
psoriasis patients in Malaysia. Although cardiovascular
diseases are well-known to cause significant morbidity and
mortality among psoriasis patients, the role of infections
and malignancy should not be overlooked.
Psoriasis
4.Relapsed lymphoma mimicking venous ulcer: A case report
Wan Syameen Afira Wan Ahmad Kamal ; Azura Mohd AFFANDI ; Anisha BHULLAR ; Wan Syazween Liyana Wan Ahmad Kamal
The Medical Journal of Malaysia 2018;73(4):253-254
Lymphoma presenting with ulceration is not typical. Wereport a case of relapsed DLBCL in a 73-year-old manpresenting with a chronic non-healing leg ulcer. He hasunderlying varicose veins with recurrent venous ulcers. This patient was diagnosed to have DLBCL six years earlier when he presented with recurrent epistaxis originating from a left nasal cavity nodule. Complete resolution was achieved after eight cycles of R-CHOP and intrathecal methotrexate. For this current problem, this patient was treated with rituximab combined with chemotherapy which resulted in healing of the ulcer.
5.A Unique Drug Rash: Bleomycin-induced Flagellate Erythema in a Patient with Hodgkin Lymphoma
See Ling Tan ; Nurul Farhana Bt Mohd Joni ; Azura Bt Mohd Affandi
Malaysian Journal of Dermatology 2022;48(Jun 2022):84-86
Summary
Flagellate erythema is characterized by “whiplike’’ linear streaks, usually following bleomycin
chemotherapy or is associated with consumption of shiitake mushrooms, dermatomyositis, adult onset
still disease as well as human immunodeficiency disease. Here, we describe a case of bleomycin-induced flagellate erythema in a patient with Hodgkin lymphoma.
Hodgkin Disease--drug therapy
6.Basal Cell Carcinoma in the Department of Dermatology, Hospital Kuala Lumpur
Rafiq Shajahan ; Siew Wen Goh ; Azura Mohd Affandi
Malaysian Journal of Dermatology 2020;44(1):30-37
Basal cell carcinoma (BCC) is the commonest skin cancer seen worldwide. This study aims to determine the clinical pattern of BCC in the Department of Dermatology, Hospital Kuala Lumpur, Malaysia
7.Management of Atopic Eczema in primary care
Ainol Haniza Kherul Anuwar ; Azura Mohd Affandi ; Ch&rsquo ; ng Chin Chwen ; Dawn Ambrose ; Heah Sheau Szu ; Khor Yek Huan ; Lalitha Pillay a/p B. Gopinathan ; Leow Wooi Leong ; Mohd. Aminuddin Mohd. Yusof ; Noor Zalmy Azizan ; Sabeera Begum ; Siti Shafatun Mohsin ; Tan Wooi Chiang ; Tarita Taib ; Wong Ping Foo ; Zaridah Zainuri ; Siti Mariam Tukimin
Malaysian Family Physician 2020;15(1):39-43
Introduction: Atopic eczema (AE) is a common infammatory skin dermatosis that is increasing
in prevalence. However, it can present in various clinical presentations, which leads to challenges
in the diagnosis and treatment of the condition, especially in a primary care setting. Te Clinical
Practice Guidelines on the Management of Atopic Eczema was developed by a multidisciplinary
development group and approved by the Ministry of Health Malaysia in 2018. It covers the aspects
of diagnosis, severity assessment, treatment, and referral.